BioCentury
ARTICLE | Clinical News

Epoetin alfa regulatory update

June 25, 2007 7:00 AM UTC

CHMP recommended the European Commission approve three applications for a biosimilar version of Eprex epoetin alfa from Johnson & Johnson (JNJ, New Brunswick, N.J.) that would be manufactured by San...